Filtered By:
Condition: Rare Diseases
Drug: Cialis
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Ambrisentan and Tadalafil Upfront Combination Therapy in Scleroderma-Associated PAH.
CONCLUSIONS: Upfront ambrisentan and tadalafil therapy significantly improved hemodynamics, RV structure and function, and functional status in treatment naïve SSc-PAH patients and may represent a very effective therapy for this patient population. In addition, we have identified novel hemodynamic and imaging biomarkers that could have potential value in future clinical trial trials. Clinical trial registration available at www.clinicaltrials.gov, ID NCT01042158.
PMID: 26360334 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - September 11, 2015 Category: Respiratory Medicine Authors: Hassoun PM, Zamanian RT, Damico R, Lechtzin N, Khair R, Kolb TM, Tedford RJ, Hulme OL, Housten T, Pisanello C, Sato T, Pullins EH, Corona-Villalobos CP, Zimmerman SL, Gashouta MA, Minai OA, Torres F, Girgis RE, Chin K, Mathai SC Tags: Am J Respir Crit Care Med Source Type: research
